SUBMIT AN ABSTRACT

Click "Begin a Submission" under the category of your choice below to submit an abstract.

GENERAL SUBMISSION INFORMATION AND DEADLINES

Don’t miss out on a great opportunity to submit an abstract for the 50th Annual ONS Congress.

ONS is accepting abstracts in the following categories:

  • General
  • Research*
  • Non-NCPD Industry Supported

*Reviewed by PhD-prepared nurses

During the submission process, you will also select a subcategory that best describes your abstract. If your abstract is accepted, it will be grouped with other abstracts in the same subcategory.

Selection of abstracts will be based solely on a blind peer review. Abstracts may be selected for oral presentation sessions or poster presentations, although you may specifiy if you are submitting for a poster only. All abstracts will be published in the online Oncology Nursing Forum .

Note: Abstracts cannot be edited after the submission deadline and will be published as received. This includes changes in authors, presenters, or results. Pay close attention to spelling, grammar, names, and credentials.

IMPORTANT DEADLINES

  • Abstract Submission Opens: Tuesday, August 13, 2024
  • Abstract Submission Deadline: Thursday, September 26, 2024, 11:59 pm ET. No extensions will be granted.

Other Questions?
Please review the abstract FAQs for common questions. If your question is not answered on the FAQs, please contact help@ons.org.

GENERAL ABSTRACTS SUBMISSIONS

  1. GUIDELINES

    1. All abstracts must be submitted by the primary author. Authors cannot be changed after the submission deadline.
    2. For abstracts with more than one author, the primary author will be the contact person and presenter. All communication will only be sent to the primary author. Changes to the contact person cannot be made after submission.
      Note: The abstract submission system allows a maximum of 6 authors. No additional authors can be added past the 6 authors.
    3. The title, authors, and organization or institution must not be included in the body of the abstract. Any references that could identify the author/investigators by name or organization within the body of the text should be removed to allow for a blind peer review.
    4. The components of the abstract should be divided and titled into the sections listed below to help authors ensure that all required information for the scoring criteria is included (See Review Process and Scoring section below). Authors should write the abstract in a word processing program (e.g. Word) using this template. Save your document in your own files to refer to when developing your presentation if accepted, then copy and paste the appropriate sections into the section headers in the abstract system. Please double check to ensure special characters (e.g. @, ©, ®) are copied correctly. No edits can be made after submission.
      1. Abstract Section Headers:
        1. Background & Significance
        2. Purpose
        3. Interventions
        4. Evaluation
        5. Discussion
      2. In addition to the sections listed, reviewers will also score your submission on the writing of the abstract and innovation of the topic.
    5. The final abstract (body of abstract) must be no more than 385 words, including the section headers. Abstracts that contain more than the specified number of words will not be reviewed. We suggest checking the word count of your abstract in a word processing program prior to copying and pasting the abstract into the online submission form. The abstract submission text box will also keep a word count.
    6. Attaching a figure or table: You may include one image file with your abstract. The image file may include more than one figure, table or image. All figures or images in the file must have titles. Words in the image file are not included in the total character count. Images will not be included in publication.
    7. Submitting your abstract:
      1. The abstract cannot be submitted unless all required fields are completed.
      2. The abstract title should clearly indicate the nature of the subject. Acronyms should not be used in the title and should be written out on first mention. A quantifiable objective should be included.
      3. The body of the abstract should be in paragraph form with appropriate section headers, using complete sentences, and avoiding special characters or symbols.
      4. No more than six authors are allowed by the system. When entering authors into the system, you will be asked for the first and last names of each author, credentials, and place of employment's name, city and state. Author information should only be included in the section where authors are added.
      5. Abstracts should have all funding sources written out completely, if applicable.
    8. The abstract must be approved for submission and presentation by the authors' employing institution(s).
    9. No previously published or presented (aka encore) abstracts will be accepted. Secondary analyses/endpoints are acceptable. Previous ONS Congress abstracts are ineligible for resubmission as they have been previously published. All submissions will be reviewed for originality via iThenticate. Abstracts identified as previously published will be removed from consideration for this ONS Congress.
    10. Data published in accepted abstracts are embargoed and may not be presented or published elsewhere until the conclusion of ONS Congress. Coverage and/or distribution of an abstract, poster, or any of its supplemental material to or by the news media, any commercial entity, or individuals, including the authors of said abstract, is strictly prohibited until the embargo is lifted.
    11. Authors retain copyright ownership of all original material submitted.
    12. Primary authors may decline acceptance or withdraw presentation of an abstract selection by emailing conferences@ons.org.

  2. GENERAL SUBCATEGORIES

    • Coordination of Care and Navigation
    • End of Life
    • Healthcare Delivery, e.g. patient flow/visits, telehealth, communication across sites, direct admits, ED
    • Management, e.g. staffing, onboarding, competency, nursing education
    • Patient Education
    • Professional Development
    • Psychosocial Dimensions of Care
    • Quality and Safety, e.g. CLABSI, Falls, Accreditation
    • Screening, Early Detection, Genomics
    • Survivorship
    • Symptom Management and Palliative Care
    • Treatment Modalities and Managing Administration, e.g. vascular access devices, hazardous drugs, infusion reactions

  3. AUTHORSHIP

    Primary authors must be either a registered nurse, a licensed healthcare professional from another discipline (physician, pharmacist, physical therapist, etc.), or a doctorally-prepared individual.

    For abstracts with more than one author, the primary author is the sole contact person and presenter. The primary author/contact person cannot be changed and is the only person who can upload information if the abstract is accepted for poster or oral presentation.

    Abstracts submitted must be of the author's own completed work, work in progress, or work previously presented at the local or regional level. Abstracts cannot be submitted that contain information that has been previously published or presented to national or international oncology nursing audiences.

    All primary abstract authors must complete the Presenter Agreement to meet the ONS NCPD Provider Unit requirements. This form is available in the submission system.

  4. REVIEW PROCESS AND SCORING

    1. Upon receipt, the abstract will be reviewed for compliance with the abstract instructions and assigned a number to ensure anonymity.
    2. Three ONS volunteers will blind review each abstract.
    3. Reviewers will use the below scoring items and criteria. Each item is scored on a 1-5 grading scale.
    4. The conference planning team will rank abstracts based on reviewer scores for acceptance and presentation at the conference. Accepted abstracts will be placed in either oral abstract podium presentations or poster presentations based on review score, unless submitted for poster only.

    Abstracts will be scored using a 1-5 ranking in each of the following criteria. See this scoring rubric for more detail.

    • Scoring
      • 5=Exceptional. Well written, clearly defined, strongly recommend.
      • 4=Good. Clear defined, recommend.
      • 3=Average. Content included, recommend.
      • 2=Poor. Content not clearly defined.
      • 1=Unacceptable. Content not defined or included, do not recommend.
    • Criteria
      • Significance and Background
        • Is the topic significant, important, or relevant to oncology nursing practice?
        • Is the unique role or contribution of nursing described?
        • Is the background of the problem summarized?
      • Purpose
        • Does the purpose clearly describe the project or activitiy?
        • Is the rationale for the topic logical and supported by the information presented?
      • Interventions
        • Does the intervention or practice describe how the purpose was accomplished?
        • Are the interventions or practices described appropriately for the topic?
        • Are nursing-sensitive patient outcome interventions described if appropriate?
      • Evaluation
        • Are the project goals evaluated according to scientific measures?
        • Are the outcomes applicable to oncology nursing?
      • Discussion
        • Are the implications for oncology nursing practice identified?
        • Are the suggestions for using the information included?
      • Reviewers will also score on:
        • Presentation
          • Is the abstract well written?
          • Are the ideas clearly communicated?
        • Innovation
          • Is this an innovative/new topic?
          • Does this have an impact on oncology nursing?

  5. PRESENTATION FORMATS

    Oral Abstracts

    Abstracts accepted for oral presentations will be scheduled with other presenters in a one-hour session grouped by related topics. Speakers will have 15 minutes to present their abstract, which includes time for questions and answers. Only one person may present the oral presentation session. Additional presenters are not permitted. Primary authors of abstracts selected for an oral presentation will be asked to submit a PowerPoint presentation. If the primary author is unable to speak at the conference, a secondary author or colleague can present on their behalf, and ONS does not need to be notified in this case.

    Poster Abstracts

    All presenters will submit their electronic poster directly to the poster system. No paper posters are allowed. Posters are available for viewing before, during, and after ONS Congress. Authors of accepted poster abstracts MUST be present at the assigned presentation monitor during their assigned session time at the conference for a 10-minute presentation about their poster and to answer questions from attendees. If the primary author is unable to speak at the conference, a secondary author or colleague can present on their behalf, and ONS does not need to be notified in this case.

RESEARCH SUBMISSIONS

  1. DEFINITION OF RESEARCH

    The ONS Congress Research Track is a forum for disseminating current findings from rigorously conducted nursing research studies. Only those abstracts that meet the definition of Research (see definitions below) should be submitted in the Research track. Those meeting the definitions of Evidence-Based Practice or Quality Improvement should be submitted in the General Abstract submission category.

    • Research: Generates new knowledge; hypothesis generating or hypothesis testing; a process of systematic inquiry, data collection, and analysis and interpretation of data that contribute to generalizable knowledge.
      Example: Comparing associations between DNA methylation and patient-reported outcomes among patients who do and do not engage in exercise while undergoing treatment for cancer.
    • Evidence-Based Practice: The utilization of scientific evidence (derived from research studies), patient preferences, and clinician expertise to optimize patient care.
      Example: Incorporating a previously tested exercise teaching sheet in the clinical setting for patients undergoing treatment for cancer.
    • Quality Improvement: Data-driven method to improve processes specific to an institution / organization.
      Example: Changing patient flow through clinical appointments for patients undergoing treatment for cancer to optimize time for providing exercise teaching sheets while maintaining daily numbers of patient visits.

    When submitting your Research abstract, you will be asked to select a subcategory to indicate the ONS Research Priority to which your abstract most closely aligns. Notably, some studies / projects may not be clearly delineated within one of these categories. If you are unsure of which track to submit your abstract to, please contact conferences@ONS.org.

    Reference:
    Carter EJ, Mastro K, Vose C, Rivera R, Larson EL. Clarifying the Conundrum: Evidence-Based Practice, Quality Improvement, or Research?: The Clinical Scholarship Continuum. J Nurs Adm. 2017 May;47(5):266-270. doi: 10.1097/NNA.0000000000000477. PMID: 28422932.

  2. GUIDELINES

    1. All abstracts must be submitted by the primary author. Authors cannot be changed after the submission deadline.
    2. The title, authors and organization must not be included in the body of the abstract. Any references that could identify the author/investigators by name or organization within the body of the text should be removed to allow for a blind peer review.
    3. The components of the abstract should be divided and titled into the following sections to help authors ensure that all required information for the scoring criteria is included. Authors should write the abstract in a word processing program (e.g. Word) using this template. Save your document in your own files to refer to when developing your presentation, then copy and paste the appropriate sections into the section headers in the abstract system. Please double check to ensure special characters are copied correctly. No edits can be made after submission and prior to publishing.
      1. Abstract Section Headers:
        1. Significance & Background
        2. Purpose
        3. Interventions
        4. Evaluation
        5. Discussion
    4. The final abstract (body of abstract) must be no more than 385 words, including the section headers. Abstracts that contain more than the specified number of words will not be reviewed. We suggest checking the word count of your abstract in a word processing program prior to copying and pasting the abstract into the online submission form.
    5. Attaching a figure or table: You may include one image file with your abstract. The image file may include more than one figure, table or image. All figures or images in the file must have titles. Words in the image file are not included in the total character count. Images will not be included in publication.
    6. To submit your abstract:
      1. The abstract cannot be submitted unless all required fields are completed.
      2. The abstract title should clearly indicate the nature of the subject. Acronyms should not be used in the title and should be written out on first mention.
      3. The body of the abstract should be in paragraph form with appropriate section headers, using complete sentences, and avoiding special characters, e.g. Σ, ©
      4. No more than six authors are allowed by the system. When entering authors into the system, you will be asked for the first and last names of each author, credentials, and place of employment's name, city and state.
      5. Abstracts should have all funding sources included.
    7. The abstract must be approved for submission and presentation by the authors' employing institution(s).
    8. No previously published or presented (aka encore) abstracts will be accepted. Secondary analyses/endpoints are acceptable. Previous ONS Congress abstracts are ineligible for resubmission as they have been previously published. All submissions will be reviewed for originality via iThenticate. Abstracts identified as previously published will be removed from consideration for this ONS Congress.
    9. Research in progress will be considered for e-Poster presentation only. Consider submitting abstract in late breaking call for abstracts (December 3, 2024 - January 7, 2025).
    10. Data published in accepted abstracts are embargoed and may not be presented or published elsewhere until the conclusion of ONS Congress. Coverage and/or distribution of an abstract, poster, or any of its supplemental material to or by the news media, any commercial entity, or individuals, including the authors of said abstract, is strictly prohibited until the embargo is lifted.
    11. Authors retain copyright ownership of all original material submitted.
    12. Primary authors may decline acceptance or withdraw presentation of an abstract selection by emailing conferences@ons.org.

  3. RESEARCH SUBCATEGORIES

    • Data Science
    • Genetics
    • Healthcare delivery, care models, nursing workforce
    • Health Equity, including age, gender, SDOH, environment
    • Survivorship, Palliative and Psychosocial Oncology Care
    • Symptom Science
    • Translation / Implementation Sciences
    • Caregiving

  4. AUTHORSHIP

    Primary authors must be either a registered nurse, a licensed healthcare professional from another discipline (physician, pharmacist, physical therapist, etc.), or a doctorally-prepared individual.

    For abstracts with more than one author, the primary author is the sole contact person and presenter. The primary author/contact person may not be changed and is the only person who can upload information if the abstract is accepted for poster or oral presentation.

    Abstracts submitted must be of the author's own completed work, work in progress, or work previously presented at the local or regional level. Abstracts may not be submitted that contain information that has been previously published or presented to national or international oncology nursing audiences.

    All primary abstract authors must complete the Presenter Agreement to meet the ONS NCPD Provider Unit requirements. This form is available in the submission system.

  5. REVIEW PROCESS AND SCORING

    1. Upon receipt, the abstract will be reviewed for compliance with the abstract instructions and assigned a number to ensure anonymity.
    2. Three PhD-prepared ONS volunteers will blind review each abstract.
    3. Abstracts will be scored using a 1-5 ranking on the following criteria. View the complete research scoring rubric here. Abstract scoring adapted (with permission) from the 2019 International Nursing Association for Clinical Simulation and Learning (INACSL) Research Rubric.
    4. The conference planning team will rank abstracts for acceptance and presentation at the conference. Accepted abstracts will be placed in either Oral Abstract Podium presentations or Poster presentations based on review and score, unless submitted for poster presentations only.

    Abstracts will be scored using the following scoring and criteria.

    • Scoring
      • 5=Excellent. Clearly conveys the information for the section and appropriate to the topic. Strongly recommend.
      • 4=Very Good. Mostly clear, appropriate and consistent to section. Recommend.
      • 3=Good. Partially clear, appropriate and consistent to section. Recommend.
      • 2=Developing. Not adequately described, key elements missing.
      • 1=Emerging. Unclear, not consistent with section. Do not recommend.
    • Criteria
      • Title
        • Does the title clearly convey the study design, variables and study population?
        • Is the title fully relevant to oncology nursing science?
      • Purpose and Problem Statement
        • Is the purpose/problem statement fully clear?
      • Significance
        • Does the content fully address gaps and current literature to further oncology nursing science?
      • Methods
        • Is the study design, sampling methods, sample size, procedures, instruments, and data analysis fully appropriate and consistent with the purpose of the study?
      • Findings and Interpretation
        • The results or the salient findings are fully summarized, and the author(s) interpretation of the data is fully presented.
      • Discussion and Implications
        • Is discussion fully clear, logical and congruent with the study's purpose, methods, or findings?
        • Do findings fully define implications for nursing science, patient outcomes, nursing practice, education, administration, leadership and/or policy making?
      • Reviewers will also score on:
        • Presentation
          • Is the writing style fully scholarly and fully clear to the reader?
          • Is the abstract free of spelling or grammatical errors, and does the author use appropriate wording?
        • Innovation
          • Is this a fully innovative approach (e.g., topic and/or methods)?
          • Does this have an impact on oncology nursing?

  6. ABSTRACT PRESENTATION FORMATS

    Oral Abstracts

    Abstracts accepted for oral presentations will be scheduled with other presenters in a one-hour session grouped by related topics. Speakers will have 15 minutes to present their abstract, which includes time for questions and answers. Only one person may present the oral presentation session. Additional presenters are not permitted. Primary authors of abstracts selected for an oral presentation will be asked to submit a PowerPoint presentation. If the primary author is unable to speak at the conference, a secondary author or colleague can present on their behalf, and ONS does not need to be notified in this case.

    Poster Abstracts

    All presenters will submit their electronic poster directly to the poster system. No paper posters are allowed. Posters are available for viewing before, during, and after ONS Congress. Authors of accepted poster abstracts MUST be present at the assigned presentation monitor during their assigned session time at the conference for a 10-minute presentation about their poster and to answer questions from attendees. If the primary author is unable to speak at the conference, a secondary author or colleague can present on their behalf, and ONS does not need to be notified in this case.

INDUSTRY-SUPPORTED ABSTRACT SUBMISSIONS

  1. INFORMATION ABOUT THIS CATEGORY

    Industry-supported abstracts are identified as projects or research where the researcher or presenter is an employee of a pharmaceutical or related company. Also, any project that has been solely funded or directed by a company would be considered industry supported. Projects that have received unrestricted grant funding in which the researcher or principal investigator maintained full control over the project would not be considered industry supported.

    Pharmaceutical company or industry employees may submit an abstract featuring their employer’s products or services if they fully disclose their employment and/or financial involvement. Abstract presentations may not be sales presentations and must not imply the ONS's endorsement of said products or services. The individual making the presentation must clarify this point during the presentation. All pharmaceutical or industry sponsored abstracts are strongly encouraged to address nursing role, implications for nursing research, or clinical practice.

    Researchers wishing to submit an abstract containing data related to a clinical pharmaceutical or industry trial conducted at their institution, must provide full disclosure of the presenter’s affiliation with the company, any financial gains (honoraria, travel reimbursement etc.) received, research support obtained, or involvement of the company in the research, as well as a complete list of all contributors (physicians, statisticians etc.) on the abstract submission. Failure to provide such disclosure will result in the automatic rejection of the abstract. The member is expected to add a nursing dimension to the existing clinical trial data to make such data interesting and applicable to the conference attendees.

    NCPD will not be awarded for these abstracts due to ANCC guidelines stating that content must be free of commercial influence. These abstracts will only be accepted for poster presentation.

  2. GUIDELINES

    1. All abstracts must be submitted by the primary author. Authors cannot be changed after the submission deadline.
    2. For abstracts with more than one author, the primary author will be the contact person and presenter. All communication will be sent to the primary author only. Changes to the contact person cannot be made after submission.
      Note: The abstract submission system allows a maximum of 6 authors. No additional authors can be added past the 6 authors.
    3. The title and authors must not be included in the body of the abstract. Any references that could identify the author/investigators by name or organization within the body of the text should be removed to allow for a blind peer review.
    4. The components of the abstract should be divided and titled into the sections listed below to help authors ensure that all required information based upon the scoring criteria is included (See Review Process and Scoring section below.). Authors should write the abstract in a word processing program (e.g. Word) using this template. Save your document in your own files to refer to when developing your presentation if accepted, then copy and paste the appropriate sections into the section headers in the abstract system. Please double check to ensure special characters (e.g. @, ©, ®) are copied correctly. No edits can be made after submission.
      1. Abstract Section Headers:
        1. Significance & Background
        2. Purpose
        3. Interventions
        4. Evaluation
        5. Discussion
      2. In addition to the sections listed, reviewers will also score your submission on the appearance of the abstract and innovation of the topic.
    5. The final abstract (body of abstract) must be no more than 385 words, including the section headers. Abstracts that contain more than the specified number of words will not be reviewed. We suggest checking the word count of your abstract in a word processing program prior to copying and pasting the abstract into the online submission form. The abstract submission text box will also note a word count.
    6. Attaching a figure or table: You may include one image file with your abstract. The image file may include more than one figure, table or image. All figures or images in the file must have titles. Words in the image file are not included in the total character count. Images will not be included in publication.
    7. Submitting your abstract:
      1. The abstract cannot be submitted unless all required fields are completed.
      2. The abstract title should clearly indicate the nature of the subject. Acronyms should not be used in the title and should be written out on first mention. A quantifiable objective should be included.
      3. The body of the abstract should be in paragraph form with appropriate section headers, using complete sentences, and avoiding special characters or symbols, e.g. ™, ©.
      4. No more than six authors are allowed by the system. When entering the system, you will be asked for the first and last names of each author, credentials, and place of employment's name, city and state. Author information should only be included in the section where authors are added.
      5. Abstracts should have all funding sources written out completely, if applicable.
    8. The abstract must be approved for submission and presentation by the authors' employing institution(s).
    9. No previously published or presented (aka encore) abstracts will be accepted. Secondary analyses/endpoints are acceptable. Previous ONS Congress abstracts are ineligible for resubmission as they have been previously published. All submissions will be reviewed for originality via iThenticate. Abstracts identified as previously published will be removed from consideration for this ONS Congress.
    10. Data published in accepted abstracts are embargoed and may not be presented or published elsewhere until the conclusion of ONS Congress. Coverage and/or distribution of an abstract, poster, or any of its supplemental material to or by the news media, any commercial entity, or individuals, including the authors of said abstract, is strictly prohibited until the embargo is lifted.
    11. Authors retain copyright ownership of all original material submitted.
    12. Primary authors may decline acceptance or withdraw presentation of an abstract selection by emailing conferences@ons.org.
    13. Trials in progress will be considered for e-Poster presentation only. Consider submitting abstract in late breaking call for abstracts (December 3, 2024 - January 7, 2025) if data isn't available for first abstract call.

  3. AUTHORSHIP

    Primary authors must be either a registered nurse, a licensed healthcare professional from another discipline (physician, pharmacist, physical therapist, etc.), or a doctorally-prepared individual.

    For abstracts with more than one author, the primary author is the sole contact person and presenter. The primary author/contact person may not be changed and is the only person who can upload information if the abstract is accepted for poster or oral presentation.

    Abstracts submitted must be of the author's own completed work, work in progress, or work previously presented at the local or regional level. Abstracts may not be submitted that contain information that has been previously published or presented to national or international oncology nursing audiences.

    All primary abstract authors must complete the Presenter Agreement. This form is available in the submission system.

  4. REVIEW PROCESS AND SCORING

    1. Upon receipt, the abstract will be reviewed for compliance with the abstract instructions and assigned a number to ensure anonymity.
    2. Three ONS volunteers will blind review each abstract.
    3. Reviewers will use the below scoring items and criteria. Each item is scored on a 1-5 grading scale.
    4. The conference planning team will rank abstracts based on reviewer scores for acceptance and presentation at the conference. Accepted abstracts will be placed in an Industry-Supported poster session.

    Abstracts will be scored using a 1-5 ranking in each of the following criteria. See the scoring rubric for more detail.

    • Scoring
      • 5=Exceptional. Well written, clearly defined, strongly recommend.
      • 4=Good. Clearly defined, recommend.
      • 3=Average. Content included, recommend.
      • 2=Poor. Content not clearly defined.
      • 1=Unacceptable. Content not defined or included, do not recommend.
    • Criteria
      • Significance and Background
        • Is the topic significant, important, or relevant to oncology nursing practice?
        • Is the unique role or contribution of nursing described?
        • Is the background of the problem summarized?
      • Purpose
        • Does the purpose clearly describe the project or activity?
        • Is the rationale for the topic logical and supported by the information presented?
      • Interventions
        • Does the intervention or practice describe how the purpose was accomplished?
        • Are the interventions or practices described appropriately for the topic?
        • Are nursing-sensitive patient outcome interventions described if appropriate?
      • Evaluation
        • Are the project goals evaluated according to specific measures?
        • Are the outcomes applicable to oncology nursing?
      • Discussion
        • Are the implications for oncology nursing practice identified?
        • Are the suggestions for using the information included?
      • Reviewers will also score on:
        • Presentation
          • Is the abstract well written?
          • Are the ideas clearly communicated?
        • Innovation
          • Is this an innovative/new topic?
          • Does this have an impact on oncology nursing?

  5. PRESENTATION FORMAT

    Poster Presentations

    All presenters will submit their electronic poster directly to the poster system. No paper posters are allowed. Posters are available for viewing before, during, and after ONS Congress. Authors of accepted poster abstracts MUST be present at the assigned presentation monitor during their assigned session time at the conference for a 10-minute presentation about their poster and to answer questions from attendees. If the primary author is unable to speak at the conference, a secondary author or colleague can present on their behalf, and ONS does not need to be notified in this case.

BEGIN A SUBMISSION

GENERAL ABSTRACTS

Submission Deadline:
Thursday, September 26, 2024
11:59 pm ET

INDUSTRY-SUPPORTED

Submission Deadline:
Thursday, September 26, 2024
11:59 pm ET

RESEARCH

Submission Deadline:
Thursday, September 26, 2024
11:59 pm ET